Gyulai Orsolya, Kovács Anita, Sovány Tamás, Csóka Ildikó, Aigner Zoltán
Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, 6720 Szeged, Hungary.
Materials (Basel). 2018 Apr 20;11(4):635. doi: 10.3390/ma11040635.
This research work presents the use of the Quality by Design (QbD) concept for optimization of the spherical agglomeration crystallization method in the case of the active agent, ambroxol hydrochloride (AMB HCl). AMB HCl spherical crystals were formulated by the spherical agglomeration method, which was applied as an antisolvent technique. Spherical crystals have good flowing properties, which makes the direct compression tableting method applicable. This means that the amount of additives used can be reduced and smaller tablets can be formed. For the risk assessment, LeanQbD Software was used. According to its results, four independent variables (mixing type and time, dT (temperature difference between solvent and antisolvent), and composition (solvent/antisolvent volume ratio)) and three dependent variables (mean particle size, aspect ratio, and roundness) were selected. Based on these, a 2⁻3 mixed-level factorial design was constructed, crystallization was accomplished, and the results were evaluated using Statistica for Windows 13 program. Product assay was performed and it was revealed that improvements in the mean particle size (from ~13 to ~200 µm), roundness (from ~2.4 to ~1.5), aspect ratio (from ~1.7 to ~1.4), and flow properties were observed while polymorphic transitions were avoided.
本研究工作介绍了在盐酸氨溴索(AMB HCl)活性剂的情况下,采用质量源于设计(QbD)概念优化球形团聚结晶法。AMB HCl球形晶体通过球形团聚法制备,该方法作为一种抗溶剂技术应用。球形晶体具有良好的流动性,这使得直接压片法适用。这意味着可以减少添加剂的用量,并能制成更小的片剂。为了进行风险评估,使用了LeanQbD软件。根据其结果,选择了四个自变量(混合类型和时间、dT(溶剂和抗溶剂之间的温差)以及组成(溶剂/抗溶剂体积比))和三个因变量(平均粒径、纵横比和圆度)。基于这些,构建了一个2⁻³混合水平析因设计,完成了结晶,并使用Windows 13版的Statistica程序对结果进行了评估。进行了产品分析,结果表明,平均粒径(从约13μm提高到约200μm)、圆度(从约2.4提高到约1.5)、纵横比(从约1.7提高到约1.4)和流动性均有所改善,同时避免了多晶型转变。